Request a copy

Full Text

• Pfeffer, M., Dobler, G., Emergence of zoonotic arboviruses by animal trade and migration (2010) Parasites & Vectors, 3, p. 35
• Adams, A.P., Navarro-Lopez, R., Ramirez-Aguilar, F.J., Lopez-Gonzalez, I., Leal, G., Flores-Mayorga, J.M., Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010 (2012) PLoS Neglected Tropical Diseases, 6, pp. e1875
• MacKay, R.J., Alphaviral encephalomyelitis (EEE, WEE and VEE) (2009) Infectious diseases of the horse, pp. 95-108. , Equine Veterinary Journal, Geerings Print Ltd., Ashford, Kent, UK, T.S. Mair, R.E. Hutchinson (Eds.)
• Equine encephalomyelitis (Eastern and Western) (2012) Manual of diagnostic tests and vaccines for terrestrial animals, pp. 852-859. , [OIE] WOfAH, OIE, Paris, France, O.B.S. Commission (Ed.)
• Venezuelan equine encephalomyelitis (2012) Manual for diagnostic tests and vaccines for terrestrial animals, pp. 924-929. , [OIE] WOfAH, OIE, Paris, France, O.B.S. Commission (Ed.)
• Pandya, J., Gorchakov, R., Wang, E., Leal, G., Weaver, S.C., A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation (2012) Vaccine, 30, pp. 1276-1282
• Roy, C.J., Adams, A.P., Wang, E., Leal, G., Seymour, R.L., Sivasubramani, S.K., A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus (2013) Vaccine, 31, pp. 1464-1470
• Barabe, N.D., Rayner, G.A., Christopher, M.E., Nagata, L.P., Wu, J.Q., Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus (2007) Vaccine, 25, pp. 6271-6276
• Atasheva, S., Wang, E., Adams, A.P., Plante, K.S., Ni, S., Taylor, K., Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus (2009) Vaccine, 27, pp. 4309-4319
• Williams, A.J., O'Brien, L.M., Phillpotts, R.J., Perkins, S.D., Improved efficacy of a gene optimised adenovirus-based vaccine for Venezuelan equine encephalitis virus (2009) Virology Journal, 6, p. 118
• Tretyakova, I., Lukashevich, I.S., Glass, P., Wang, E., Weaver, S., Pushko, P., Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine (2013) Vaccine, 31, pp. 1019-1025
• Perkins, S.D., O'Brien, L.M., Phillpotts, R.J., Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination (2006) Vaccine, 24, pp. 3440-3445
• Minke, J.M., Audonnet, J.C., Fischer, L., Equine viral vaccines: the past, present and future (2004) Veterinary Research, 35, pp. 425-443
• Bertone, J.J., Viral encephalitis (2010) Equine internal medicine, pp. 624-628. , Saunders, St. Louis, MO, S.M. Reed, W.M. Bayly, D.C. Sellon (Eds.)
• Weaver, S.C., Powers, A.M., Brault, A.C., Barrett, A.D., Molecular epidemiological studies of veterinary arboviral encephalitides (1999) Veterinary Journal, 157, pp. 123-138
• Taylor, K.G., Paessler, S., Pathogenesis of Venezuelan equine encephalitis (2013) Veterinary Microbiology
• (2008) Eastern equine encephalomyelitis, Western equine encephalomyelitis and Venezuelan equine encephalomyelitis, pp. 1-10. , CfFSaPH, College of Veterinary Medicine, Iowa State University
• MacLachlan, N.J., Dubovi, E.J., Fenner' veterinary virology (2010) Togaviridae, pp. 456-464. , Academic Press, London, UK, N.J. MacLachlan, E.J. Dubovi (Eds.)
• Gibbs, E.P.J., Long, M.T., Equine alphaviruses (2007) Equine infectious diseases, pp. 191-197. , Saunders, St. Louis, MO, USA, D.C. Sellon, M.T. Long (Eds.)
• Steele, K.E., Reed, D.S., Glass, P.J., Hart, M.K., Ludwig, G.V., Pratt, W.D., (2008) Alphavirus encephalitides, pp. 241-270. , Medical Aspects of Biological Warfare, Department of the Army
• Zacks, M.A., Paessler, S., Encephalitic alphaviruses (2010) Veterinary Microbiology, 140, pp. 281-286
• Weaver, S.C., Ferro, C., Barrera, R., Boshell, J., Navarro, J.C., Venezuelan equine encephalitis (2004) Annual Review of Entomology, 49, pp. 141-174
• Aguilar, P.V., Paessler, S., Carrara, A.S., Baron, S., Poast, J., Wang, E., Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus (2005) Journal of Virology, 79, pp. 11300-11310
• Wang, E., Petrakova, O., Adams, A.P., Aguilar, P.V., Kang, W., Paessler, S., Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice (2007) Vaccine, 25, pp. 7573-7581
• Logue, C.H., Bosio, C.F., Welte, T., Keene, K.M., Ledermann, J.P., Phillips, A., Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model (2009) The Journal of General Virology, 90, pp. 1848-1858
• Phillpotts, R.J., O'Brien, L., Appleton, R.E., Carr, S., Bennett, A., Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus (2005) Vaccine, 23, pp. 1615-1623
• Oberste, M.S., Schmura, S.M., Weaver, S.C., Smith, J.F., Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico (1999) The American Journal of Tropical Medicine and Hygiene, 60, pp. 630-634
• Fine, D.L., Roberts, B.A., Teehee, M.L., Terpening, S.J., Kelly, C.L., Raetz, J.L., Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses (2007) Vaccine, 25, pp. 1868-1876
• Hodgson, L.A., Ludwig, G.V., Smith, J.F., Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors (1999) Vaccine, 17, pp. 1151-1160
• Zhang, R., Hryc, C.F., Cong, Y., Liu, X., Jakana, J., Gorchakov, R., 4.4A° cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus (2011) EMBO Journal, 30, pp. 3854-3863
• Griffin, D., Alphaviruses (2007) Field virology, pp. 1023-1067. , Lippincott Williams & Wilkins, Philadelphia, USA, D. Knipe, P. Howley, D. Griffin, R. Lamb, M. Martin, B. Roizman (Eds.)
• Gauci, P.J., Wu, J.Q., Rayner, G.A., Barabe, N.D., Nagata, L.P., Proll, D.F., Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination (2010) Clinical and Vaccine Immunology: CVI, 17, pp. 176-179
• Netolitzky, D.J., Schmaltz, F.L., Parker, M.D., Rayner, G.A., Fisher, G.R., Trent, D.W., Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes (2000) The Journal of General Virology, 81, pp. 151-159
• Das, D., Gares, S.L., Nagata, L.P., Suresh, M.R., Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics (2004) Antiviral Research, 64, pp. 85-92
• Das, D., Nagata, L.P., Suresh, M.R., Immunological evaluation of Escherichia coli expressed E2 protein of Western equine encephalitis virus (2007) Virus Research, 128, pp. 26-33
• Hu, W.G., Chau, D., Wong, C., Masri, S.A., Fulton, R.E., Nagata, L.P., Cloning, expression and purification of envelope proteins E1 and E2 of western equine encephalitis virus and potential use of them as antigens in immunoassays (2008) Veterinary Microbiology, 128, pp. 374-379
• Wilson, D.W., Pusterla, N., Immunoprophylaxis (2007) Equine infectious diseases, pp. 556-577. , Saunders, St. Louis, MO, USA, D.C. Sellon, M.T. Long (Eds.)
• Pratt, W.D., Davis, N.L., Johnston, R.E., Smith, J.F., Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models (2003) Vaccine, 21, pp. 3854-3862
• Rossi, S.L., Guerbois, M., Gorchakov, R., Plante, K.S., Forrester, N.L., Weaver, S.C., IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice (2013) Virology, 437, pp. 81-88
• Paessler, S., Weaver, S.C., Vaccines for Venezuelan equine encephalitis (2009) Vaccine, 27 (SUPPL. 4), pp. D80-D85
• Dupuy, L.C., Locher, C.P., Paidhungat, M., Richards, M.J., Lind, C.M., Bakken, R., Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine (2009) Vaccine, 27, pp. 4152-4160
• Paessler, S., Fayzulin, R.Z., Anishchenko, M., Greene, I.P., Weaver, S.C., Frolov, I., Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic (2003) Journal of Virology, 77, pp. 9278-9286
• Toth, A.M., Geisler, C., Aumiller, J.J., Jarvis, D.L., Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system (2011) Protein Expression and Purification, 80, pp. 274-282
• Schoepp, R.J., Smith, J.F., Parker, M.D., Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates (2002) Virology, 302, pp. 299-309
• Davis, N.L., Brown, K.W., Greenwald, G.F., Zajac, A.J., Zacny, V.L., Smith, J.F., Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1 (1995) Virology, 212, pp. 102-110
• Hart, M.K., Lind, C., Bakken, R., Robertson, M., Tammariello, R., Ludwig, G.V., Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice (2001) Vaccine, 20, pp. 616-622
• Reed, D.S., Lind, C.M., Lackemeyer, M.G., Sullivan, L.J., Pratt, W.D., Parker, M.D., Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus (2005) Vaccine, 23, pp. 3139-3147
• Turell, M.J., Ludwig, G.V., Kondig, J., Smith, J.F., Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates (1999) The American Journal of Tropical Medicine and Hygiene, 60, pp. 1041-1044
• Nagata, L.P., Hu, W.G., Masri, S.A., Rayner, G.A., Schmaltz, F.L., Das, D., Efficacy of DNA vaccination against western equine encephalitis virus infection (2005) Vaccine, 23, pp. 2280-2283
• Garmashova, N., Atasheva, S., Kang, W., Weaver, S.C., Frolova, E., Frolov, I., Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription (2007) Journal of Virology, 81, pp. 13552-13565
• Aguilar, P.V., Weaver, S.C., Basler, C.F., Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression (2007) Journal of Virology, 81, pp. 3866-3876
• Atasheva, S., Fish, A., Fornerod, M., Frolova, E.I., Venezuelan equine Encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha/beta that obstructs nuclear pore complex function (2010) Journal of Virology, 84, pp. 4158-4171
• Riemenschneider, J., Garrison, A., Geisbert, J., Jahrling, P., Hevey, M., Negley, D., Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus (2003) Vaccine, 21, pp. 4071-4080
• Dupuy, L.C., Richards, M.J., Reed, D.S., Schmaljohn, C.S., Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates (2010) Vaccine, 28, pp. 7345-7350
• Dupuy, L.C., Richards, M.J., Ellefsen, B., Chau, L., Luxembourg, A., Hannaman, D., A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates (2011) Clinical and Vaccine Immunology: CVI, 18, pp. 707-716
• Yun, N.E., Peng, B.H., Bertke, A.S., Borisevich, V., Smith, J.K., Smith, J.N., CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus (2009) Vaccine, 27, pp. 4064-4073
• Tatsis, N., Erlt, H.C.J., Adenoviruses as vaccine vectors (2004) Molecular Therapy, 10, p. 14
• Wu, J.Q., Barabe, N.D., Chau, D., Wong, C., Rayner, G.R., Hu, W.G., Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine (2007) Vaccine, 25, pp. 4368-4375
• Schmaljohn, A.L., Johnson, E.D., Dalrymple, J.M., Cole, G.A., Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis (1982) Nature, 297, pp. 70-72
• Weaver, S.C., Kang, W., Shirako, Y., Rumenapf, T., Strauss, E.G., Strauss, J.H., Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses (1997) Journal of Virology, 71, pp. 613-623
• Ni, H., Yun, N.E., Zacks, M.A., Weaver, S.C., Tesh, R.B., da Rosa, A.P., Recombinant alphaviruses are safe and useful serological diagnostic tools (2007) The American Journal of Tropical Medicine and Hygiene, 76, pp. 774-781
• Saade, F., Petrovsky, N., Technologies for enhanced efficacy of DNA vaccines (2012) Expert Review of Vaccines, 11, pp. 189-209
• Li, L., Saade, F., Petrovsky, N., The future of human DNA vaccines (2012) Journal of Biotechnology, 162, pp. 171-182
• Davis, B.S., Chang, G.J., Cropp, B., Roehrig, J.T., Martin, D.A., Mitchell, C.J., West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays (2001) Journal of Virology, 75, pp. 4040-4047
• De Filette, M., Ulbert, S., Diamond, M., Sanders, N.N., Recent progress in West Nile virus diagnosis and vaccination (2012) Veterinary Research, 43, p. 16
• Gurunathan, S., Wu, C.Y., Freidag, B.L., Seder, R.A., DNA vaccines: a key for inducing long-term cellular immunity (2000) Current Opinion in Immunology, 12, pp. 442-447
• Shedlock, D.J., Weiner, D.B., DNA vaccination: antigen presentation and the induction of immunity (2000) Journal of Leukocyte Biology, 68, pp. 793-806
• Gurunathan, S., Klinman, D.M., Seder, R.A., DNA vaccines: immunology, application, and optimization* (2000) Annual Review of Immunology, 18, pp. 927-974
• Fischer, L., Minke, J., Dufay, N., Baudu, P., Audonnet, J.C., Rabies DNA vaccine in the horse: strategies to improve serological responses (2003) Vaccine, 21, pp. 4593-4596
• Pacheco, J.M., Brum, M.C., Moraes, M.P., Golde, W.T., Grubman, M.J., Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine (2005) Virology, 337, pp. 205-209
• Gogev, S., Vanderheijden, N., Lemaire, M., Schynts, F., D'Offay, J., Deprez, I., Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD (2002) Vaccine, 20, pp. 1451-1465
• El Garch, H., Minke, J.M., Rehder, J., Richard, S., Edlund Toulemonde, C., Dinic, S., A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse (2008) Veterinary Immunology and Immunopathology, 123, pp. 230-239
• Soboll, G., Hussey, S.B., Minke, J.M., Landolt, G.A., Hunter, J.S., Jagannatha, S., Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination (2010) Veterinary Immunology and Immunopathology, 135, pp. 100-107
• Seino, K.K., Long, M.T., Gibbs, E.P., Bowen, R.A., Beachboard, S.E., Humphrey, P.P., Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model (2007) Clinical and Vaccine Immunology: CVI, 14, pp. 1465-1471
• Durand, B., Lecollinet, S., Beck, C., Martinez-Lopez, B., Balenghien, T., Chevalier, V., Identification of hotspots in the European union for the introduction of four zoonotic arboviroses by live animal trade (2013) PLoS one, 8, pp. e70000